课题基金 / 基金详情

Identification of therapeutic targets for pediatric acute megakaryoblastic leukemia

Identification of therapeutic targets for pediatric acute megakaryoblastic leukemia
儿童急性巨核细胞白血病治疗靶点的确定
批准号:
370619
负责人:
Mallette Frdrick A
金额:
$55.73万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-09-01 至 2022-09-01

项目摘要

项目成果

Mallette Frdrick A的其他基金

相似基金

相关文献

中文摘要
翻译
在加拿大,近四分之一的儿童癌症是白血病。令人鼓舞的是,许多儿童白血病现在可以用各种抗癌药物治疗。尽管如此,白血病仍然占癌症相关死亡的25%
英文摘要
In Canada, nearly one quarter of childhood cancers are leukemias. Encouragingly, many of these pediatric leukemias are now treatable with a variety of anti-cancer drugs. Nonetheless, leukemia still accounts for an alarming ~25% of cancer-related deaths in
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying novel therapeutic vulnerabilities in pediatric acute megakaryoblastic leukemia
Exploiting translational reprogramming in neoplasia to devise unique strategies to eliminate cancer and cancer-promoting senescent cells
Canada Research Chairs - Tier 2
  • 批准号:
    441821
  • 项目类别:
  • 资助金额:
    $36.43万
  • 财政年份:
    2020
  • 负责人:
    Mallette Frdrick A
  • 依托单位:
Cholesterol metabolism and regulation of the senescence-associated secretory phenotype in retinopathy
海外基金